- Home
- FGEN vs LRE Comparison
FGEN vs LRE Comparison
Compare FGEN & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- LRE
- Stock Information
- Founded
- FGEN 1993
- LRE 2001
- Country
- FGEN United States
- LRE Japan
- Employees
- FGEN N/A
- LRE N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- FGEN Health Care
- LRE
- Exchange
- FGEN Nasdaq
- LRE Nasdaq
- Market Cap
- FGEN 34.5M
- LRE 29.9M
- IPO Year
- FGEN 2014
- LRE 2023
- Fundamental
- Price
- FGEN $0.36
- LRE $1.90
- Analyst Decision
- FGEN
- LRE
- Analyst Count
- FGEN 0
- LRE 0
- Target Price
- FGEN N/A
- LRE N/A
- AVG Volume (30 Days)
- FGEN 911.8K
- LRE 28.6K
- Earning Date
- FGEN 11-12-2024
- LRE 01-01-0001
- Dividend Yield
- FGEN N/A
- LRE N/A
- EPS Growth
- FGEN N/A
- LRE N/A
- EPS
- FGEN N/A
- LRE 0.29
- Revenue
- FGEN $180,015,000.00
- LRE $117,804,154.00
- Revenue This Year
- FGEN $19.67
- LRE N/A
- Revenue Next Year
- FGEN N/A
- LRE N/A
- P/E Ratio
- FGEN N/A
- LRE $6.79
- Revenue Growth
- FGEN 16.15
- LRE 8.82
- 52 Week Low
- FGEN $0.18
- LRE $1.19
- 52 Week High
- FGEN $2.93
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- FGEN 45.24
- LRE 47.06
- Support Level
- FGEN $0.31
- LRE $1.90
- Resistance Level
- FGEN $0.37
- LRE $2.34
- Average True Range (ATR)
- FGEN 0.03
- LRE 0.17
- MACD
- FGEN -0.01
- LRE -0.04
- Stochastic Oscillator
- FGEN 25.66
- LRE 25.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.